Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for GKOS

Stock Name	Glaukos Corp
Ticker	GKOS(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US3773221029
LEI	5299004JA1LHE21M6T14

Show aggregate GKOS holdings

News associated with GKOS

Zacks Research Weighs in on Glaukos’ Q3 Earnings (NYSE:GKOS): Glaukos Corporation (NYSE:GKOS – Free Report) – Investment analysts at Zacks Research lowered their Q3 2026 earnings per share (EPS) estimates for Glaukos in a note issued to investors on Wednesday, August 20th. Zacks Research analyst Team now expects that the medical instruments supplier will post earnings per share of $0.02 for the quarter, down […] - 2025-08-25 03:02:49
Vanguard Group Inc. Has $587.09 Million Holdings in Glaukos Corporation (NYSE:GKOS): Vanguard Group Inc. lowered its stake in Glaukos Corporation (NYSE:GKOS – Free Report) by 0.2% in the first quarter, Holdings Channel.com reports. The institutional investor owned 5,965,115 shares of the medical instruments supplier’s stock after selling 9,856 shares during the quarter. Vanguard Group Inc. owned approximately 0.10% of Glaukos worth $587,087,000 as of its most […] - 2025-08-14 04:37:10
Natixis Advisors LLC Cuts Stock Position in Glaukos Corporation (NYSE:GKOS): Natixis Advisors LLC lowered its holdings in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 12.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,871 shares of the medical instruments supplier’s stock after selling 4,428 shares during the quarter. Natixis […] - 2025-08-07 04:49:06
Thornburg Investment Management Inc. Has $4.96 Million Stake in Glaukos Corporation (NYSE:GKOS): Thornburg Investment Management Inc. increased its stake in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 10.6% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 50,430 shares of the medical instruments supplier’s stock after acquiring an additional 4,847 shares during the period. Thornburg […] - 2025-07-30 04:58:52
KLP Kapitalforvaltning AS Has $1.07 Million Stock Position in Glaukos Corporation (NYSE:GKOS): KLP Kapitalforvaltning AS lessened its stake in Glaukos Corporation (NYSE:GKOS – Free Report) by 4.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,900 shares of the medical instruments supplier’s stock after selling 500 shares during the quarter. KLP Kapitalforvaltning AS’s holdings […] - 2025-07-29 05:27:00
4,853 Shares in Glaukos Corporation (NYSE:GKOS) Acquired by Y Intercept Hong Kong Ltd: Y Intercept Hong Kong Ltd acquired a new position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 4,853 shares of the medical instruments supplier’s stock, valued at approximately $478,000. Several other hedge funds and other institutional investors have also recently bought and sold shares of […] - 2025-07-28 08:10:46
Envestnet Asset Management Inc. Decreases Holdings in Glaukos Corporation (NYSE:GKOS): Envestnet Asset Management Inc. decreased its position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 27.8% during the 1st quarter, Holdings Channel.com reports. The fund owned 28,038 shares of the medical instruments supplier’s stock after selling 10,817 shares during the period. Envestnet Asset Management Inc.’s holdings in Glaukos were worth $2,760,000 at the […] - 2025-07-28 04:28:50
Glaukos Corporation (NYSE:GKOS) Shares Acquired by Victory Capital Management Inc.: Victory Capital Management Inc. lifted its holdings in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 88.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 140,411 shares of the medical instruments supplier’s stock after buying an additional 66,009 shares during the period. Victory Capital […] - 2025-07-24 05:00:46
4,146 Shares in Glaukos Corporation (NYSE:GKOS) Purchased by OneAscent Financial Services LLC: OneAscent Financial Services LLC bought a new position in Glaukos Corporation (NYSE:GKOS – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 4,146 shares of the medical instruments supplier’s stock, valued at approximately $408,000. A number of other hedge funds also recently […] - 2025-07-23 06:45:09
Mutual of America Capital Management LLC Sells 324 Shares of Glaukos Corporation (NYSE:GKOS): Mutual of America Capital Management LLC decreased its position in Glaukos Corporation (NYSE:GKOS – Free Report) by 3.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,029 shares of the medical instruments supplier’s stock after selling 324 shares during the period. Mutual of […] - 2025-07-22 07:06:53
Glaukos Corporation (NYSE:GKOS) Shares Acquired by Avior Wealth Management LLC: Avior Wealth Management LLC boosted its position in Glaukos Corporation (NYSE:GKOS – Free Report) by 30.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,384 shares of the medical instruments supplier’s stock after buying an additional 782 shares during the quarter. […] - 2025-06-23 05:51:04
Glaukos Corporation (NYSE:GKOS) Stake Trimmed by Trust Point Inc.: Trust Point Inc. cut its position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 53.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,999 shares of the medical instruments supplier’s stock after selling 3,481 shares during the quarter. Trust Point Inc.’s […] - 2025-06-18 05:52:52
Glaukos Corporation (NYSE:GKOS) Receives Consensus Rating of “Moderate Buy” from Analysts: Glaukos Corporation (NYSE:GKOS – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twelve brokerages that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and ten have assigned a buy recommendation to the […] - 2025-06-18 02:52:53
Versant Capital Management Inc Purchases 327 Shares of Glaukos Co. (NYSE:GKOS): Versant Capital Management Inc boosted its position in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 583.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 383 shares of the medical instruments supplier’s stock after acquiring an additional 327 shares during the period. Versant Capital Management Inc’s holdings in Glaukos were worth […] - 2025-06-06 05:44:58
Cetera Investment Advisers Reduces Stock Position in Glaukos Co. (NYSE:GKOS): Cetera Investment Advisers lessened its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 46.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,504 shares of the medical instruments supplier’s stock after selling 1,309 shares during the quarter. Cetera Investment Advisers’ holdings in Glaukos were worth $226,000 as of its most recent SEC […] - 2025-06-02 04:34:59
Royal Bank of Canada Cuts Stake in Glaukos Co. (NYSE:GKOS): Royal Bank of Canada reduced its position in Glaukos Co. (NYSE:GKOS – Free Report) by 41.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 112,310 shares of the medical instruments supplier’s stock after selling 79,841 shares during the quarter. Royal Bank of […] - 2025-05-26 05:27:10
Focus Partners Wealth Invests $379,000 in Glaukos Co. (NYSE:GKOS): Focus Partners Wealth purchased a new position in shares of Glaukos Co. (NYSE:GKOS – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm purchased 2,528 shares of the medical instruments supplier’s stock, valued at approximately $379,000. Other large investors have also modified their holdings of the company. Rhumbline Advisers raised its stake in […] - 2025-05-22 05:08:53
Analysts See 18% Gains Ahead For USVM: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-20 07:56:36
Glaukos (NYSE:GKOS) Given New $72.00 Price Target at Morgan Stanley: Glaukos (NYSE:GKOS – Get Free Report) had its price objective decreased by stock analysts at Morgan Stanley from $110.00 to $72.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “underweight” rating on the medical instruments supplier’s stock. Morgan Stanley’s price objective suggests a potential downside of 18.40% from the company’s current […] - 2025-05-08 05:00:57
Mariner LLC Sells 783 Shares of Glaukos Co. (NYSE:GKOS): Mariner LLC cut its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 11.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,249 shares of the medical instruments supplier’s stock after selling 783 shares during the period. Mariner […] - 2025-04-28 05:08:52
Barclays PLC Acquires 2,086 Shares of Glaukos Co. (NYSE:GKOS): Barclays PLC lifted its holdings in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 2.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 91,785 shares of the medical instruments supplier’s stock after purchasing an additional 2,086 shares during the quarter. Barclays PLC’s holdings […] - 2025-04-21 05:38:46
Raymond James Financial Inc. Acquires Shares of 112,771 Glaukos Co. (NYSE:GKOS): Raymond James Financial Inc. bought a new position in Glaukos Co. (NYSE:GKOS – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 112,771 shares of the medical instruments supplier’s stock, valued at approximately $16,910,000. Several other institutional investors […] - 2025-04-21 04:40:47
Schroder Investment Management Group Acquires 6,991 Shares of Glaukos Co. (NYSE:GKOS): Schroder Investment Management Group grew its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 213.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,259 shares of the medical instruments supplier’s stock after purchasing an additional 6,991 shares during […] - 2025-04-07 05:12:52
Pictet Asset Management Holding SA Purchases 1,041 Shares of Glaukos Co. (NYSE:GKOS): Pictet Asset Management Holding SA lifted its position in Glaukos Co. (NYSE:GKOS – Free Report) by 15.9% in the 4th quarter, Holdings Channel.com reports. The fund owned 7,582 shares of the medical instruments supplier’s stock after acquiring an additional 1,041 shares during the period. Pictet Asset Management Holding SA’s holdings in Glaukos were worth $1,137,000 […] - 2025-04-06 06:25:02
Norges Bank Takes Position in Glaukos Co. (NYSE:GKOS): Norges Bank purchased a new position in shares of Glaukos Co. (NYSE:GKOS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 563,493 shares of the medical instruments supplier’s stock, valued at approximately $84,490,000. A number of other hedge funds […] - 2025-04-03 05:36:55
Glaukos Co. (NYSE:GKOS) Stock Position Lowered by Corebridge Financial Inc.: Corebridge Financial Inc. decreased its position in Glaukos Co. (NYSE:GKOS – Free Report) by 7.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 26,274 shares of the medical instruments supplier’s stock after selling 2,051 shares during the period. Corebridge Financial Inc.’s holdings in Glaukos were worth […] - 2025-03-31 05:49:01
Congress Wealth Management LLC DE Sells 400 Shares of Glaukos Co. (NYSE:GKOS): Congress Wealth Management LLC DE reduced its stake in Glaukos Co. (NYSE:GKOS – Free Report) by 22.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,389 shares of the medical instruments supplier’s stock after selling 400 shares during the period. […] - 2025-03-31 05:14:58
Glaukos Co. (NYSE:GKOS) Shares Bought by Xponance Inc.: Xponance Inc. boosted its position in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 13.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,633 shares of the medical instruments supplier’s stock after buying an additional 426 shares during the quarter. Xponance Inc.’s […] - 2025-03-26 05:56:54
Sequoia Financial Advisors LLC Trims Stock Holdings in Glaukos Co. (NYSE:GKOS): Sequoia Financial Advisors LLC lowered its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 6.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,773 shares of the medical instruments supplier’s stock after selling 117 shares during the period. Sequoia Financial Advisors LLC’s holdings in […] - 2025-03-20 06:40:56
Analysts Set Glaukos Co. (NYSE:GKOS) Price Target at $163.25: Glaukos Co. (NYSE:GKOS – Get Free Report) has earned an average rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eleven have given a buy recommendation and one has given a strong buy recommendation to […] - 2025-03-13 04:06:47

iShares US Medical Devices UCITS ETF GKOS holdings

Date	Number of GKOS Shares Held	Base Market Value of GKOS Shares	Local Market Value of GKOS Shares	Change in GKOS Base Value	Current Price per GKOS Share Held	Previous Price per GKOS Share Held
2025-12-03 (Wednesday)	7,945	USD 853,770	USD 853,770	USD 11,044	USD 107.46	USD 106.07
2025-12-02 (Tuesday)	7,945	USD 842,726	USD 842,726	USD -318	USD 106.07	USD 106.11
2025-12-01 (Monday)	7,945	USD 843,044	USD 843,044	USD -1,430	USD 106.11	USD 106.29
2025-11-28 (Friday)	7,945	USD 844,474	USD 844,474	USD 7,150	USD 106.29	USD 105.39
2025-11-27 (Thursday)	7,945	USD 837,324	USD 837,324	USD 0	USD 105.39	USD 105.39
2025-11-26 (Wednesday)	7,945	USD 837,324	USD 837,324	USD 8,263	USD 105.39	USD 104.35
2025-11-25 (Tuesday)	7,945	USD 829,061	USD 829,061	USD 49,974	USD 104.35	USD 98.06
2025-11-24 (Monday)	7,945	USD 779,087	USD 779,087	USD -12,394	USD 98.06	USD 99.62
2025-11-21 (Friday)	7,945	USD 791,481	USD 791,481	USD 35,117	USD 99.62	USD 95.2
2025-11-20 (Thursday)	7,945	USD 756,364	USD 756,364	USD -10,249	USD 95.2	USD 96.49
2025-11-19 (Wednesday)	7,945	USD 766,613	USD 766,613	USD 38,533	USD 96.49	USD 91.64
2025-11-18 (Tuesday)	7,945	USD 728,080	USD 728,080	USD 25,742	USD 91.64	USD 88.4
2025-11-17 (Monday)	7,945	USD 702,338	USD 702,338	USD -12,950	USD 88.4	USD 90.03

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of GKOS by Blackrock for IE00BMX0DF60

Show aggregate share trades of GKOS

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-06 SELL -124 84.075 81.610 81.857 USD -10,150 108.78 Profit of 3,338 on sale
2025-11-04 BUY 62 88.290 85.160 85.473 USD 5,299 109.03
2025-10-30 SELL -186 102.800 85.850 87.545 USD -16,283 109.37 Profit of 4,059 on sale
2025-10-23 SELL -62 75.260 77.070 76.889 USD -4,767 110.27 Profit of 2,070 on sale
2025-10-22 BUY 124 76.630 76.990 76.954 USD 9,542 110.46
2025-10-20 BUY 62 79.470 89.750 88.722 USD 5,501 110.82
2025-10-16 BUY 62 85.330 87.480 87.265 USD 5,410 111.10
2025-09-25 BUY 496 81.470 82.510 82.406 USD 40,873 112.90
2025-06-27 SELL -124 101.420 103.640 103.418 USD -12,824 115.95 Profit of 1,554 on sale
2025-06-12 BUY 180 97.600 98.840 98.716 USD 17,769 117.04
2025-06-10 SELL -960 95.640 96.390 96.315 USD -92,462 117.34 Profit of 20,184 on sale
2025-06-09 SELL -1,121 94.640 94.880 94.856 USD -106,334 117.52 Profit of 25,402 on sale
2025-05-30 SELL -118 94.290 95.140 95.055 USD -11,216 118.69 Profit of 2,789 on sale
2025-05-19 BUY 59 95.850 95.880 95.877 USD 5,657 120.48
2025-05-09 SELL -300 89.960 91.830 91.643 USD -27,493 122.03 Profit of 9,117 on sale
2025-04-23 SELL -60 92.610 98.860 98.235 USD -5,894 125.93 Profit of 1,662 on sale
2025-04-17 SELL -60 90.260 91.430 91.313 USD -5,479 127.50 Profit of 2,172 on sale
2025-04-10 BUY 480 89.660 91.415 91.240 USD 43,795 129.59
2025-04-04 SELL -120 83.650 85.470 85.288 USD -10,235 131.67 Profit of 5,566 on sale
2025-04-02 SELL -120 100.040 100.565 100.513 USD -12,062 132.06 Profit of 3,786 on sale
2025-03-31 SELL -180 98.420 100.470 100.265 USD -18,048 132.92 Profit of 5,877 on sale
2025-03-19 SELL -60 101.240 102.910 102.743 USD -6,165 136.19 Profit of 2,007 on sale
2025-02-28 SELL -120 120.020 120.190 120.173 USD -14,421 142.46 Profit of 2,675 on sale
2025-02-18 BUY 125 152.960 157.330 156.893 USD 19,612 143.61
2025-02-05 BUY 177 157.110 157.780 157.713 USD 27,915 142.10
2025-02-04 BUY 236 154.320 157.860 157.506 USD 37,171 141.81
2025-01-29 SELL -59 159.010 161.130 160.918 USD -9,494 140.17 Loss of -1,224 on sale
2025-01-23 SELL -59 161.220 163.710 163.461 USD -9,644 137.90 Loss of -1,508 on sale
2025-01-02 SELL -118 149.680 152.180 151.930 USD -17,928 137.54 Loss of -1,698 on sale
2024-12-04 BUY 177 138.270 140.160 139.971 USD 24,775 137.48
2024-12-03 SELL -59 136.000 138.750 138.475 USD -8,170 137.54 Loss of -55 on sale
2024-12-02 SELL -708 139.080 142.385 142.054 USD -100,575 137.48 Loss of -3,241 on sale
2024-11-29 SELL -1,180 143.650 144.420 144.343 USD -170,325 137.23 Loss of -8,393 on sale
2024-11-27 SELL -177 142.690 144.510 144.328 USD -25,546 136.76 Loss of -1,340 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-06	SELL	-124	84.075	81.610	81.857	USD -10,150	108.78 Profit of 3,338 on sale
2025-11-04	BUY	62	88.290	85.160	85.473	USD 5,299	109.03
2025-10-30	SELL	-186	102.800	85.850	87.545	USD -16,283	109.37 Profit of 4,059 on sale
2025-10-23	SELL	-62	75.260	77.070	76.889	USD -4,767	110.27 Profit of 2,070 on sale
2025-10-22	BUY	124	76.630	76.990	76.954	USD 9,542	110.46
2025-10-20	BUY	62	79.470	89.750	88.722	USD 5,501	110.82
2025-10-16	BUY	62	85.330	87.480	87.265	USD 5,410	111.10
2025-09-25	BUY	496	81.470	82.510	82.406	USD 40,873	112.90
2025-06-27	SELL	-124	101.420	103.640	103.418	USD -12,824	115.95 Profit of 1,554 on sale
2025-06-12	BUY	180	97.600	98.840	98.716	USD 17,769	117.04
2025-06-10	SELL	-960	95.640	96.390	96.315	USD -92,462	117.34 Profit of 20,184 on sale
2025-06-09	SELL	-1,121	94.640	94.880	94.856	USD -106,334	117.52 Profit of 25,402 on sale
2025-05-30	SELL	-118	94.290	95.140	95.055	USD -11,216	118.69 Profit of 2,789 on sale
2025-05-19	BUY	59	95.850	95.880	95.877	USD 5,657	120.48
2025-05-09	SELL	-300	89.960	91.830	91.643	USD -27,493	122.03 Profit of 9,117 on sale
2025-04-23	SELL	-60	92.610	98.860	98.235	USD -5,894	125.93 Profit of 1,662 on sale
2025-04-17	SELL	-60	90.260	91.430	91.313	USD -5,479	127.50 Profit of 2,172 on sale
2025-04-10	BUY	480	89.660	91.415	91.240	USD 43,795	129.59
2025-04-04	SELL	-120	83.650	85.470	85.288	USD -10,235	131.67 Profit of 5,566 on sale
2025-04-02	SELL	-120	100.040	100.565	100.513	USD -12,062	132.06 Profit of 3,786 on sale
2025-03-31	SELL	-180	98.420	100.470	100.265	USD -18,048	132.92 Profit of 5,877 on sale
2025-03-19	SELL	-60	101.240	102.910	102.743	USD -6,165	136.19 Profit of 2,007 on sale
2025-02-28	SELL	-120	120.020	120.190	120.173	USD -14,421	142.46 Profit of 2,675 on sale
2025-02-18	BUY	125	152.960	157.330	156.893	USD 19,612	143.61
2025-02-05	BUY	177	157.110	157.780	157.713	USD 27,915	142.10
2025-02-04	BUY	236	154.320	157.860	157.506	USD 37,171	141.81
2025-01-29	SELL	-59	159.010	161.130	160.918	USD -9,494	140.17 Loss of -1,224 on sale
2025-01-23	SELL	-59	161.220	163.710	163.461	USD -9,644	137.90 Loss of -1,508 on sale
2025-01-02	SELL	-118	149.680	152.180	151.930	USD -17,928	137.54 Loss of -1,698 on sale
2024-12-04	BUY	177	138.270	140.160	139.971	USD 24,775	137.48
2024-12-03	SELL	-59	136.000	138.750	138.475	USD -8,170	137.54 Loss of -55 on sale
2024-12-02	SELL	-708	139.080	142.385	142.054	USD -100,575	137.48 Loss of -3,241 on sale
2024-11-29	SELL	-1,180	143.650	144.420	144.343	USD -170,325	137.23 Loss of -8,393 on sale
2024-11-27	SELL	-177	142.690	144.510	144.328	USD -25,546	136.76 Loss of -1,340 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of GKOS

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	155,980	0	408,297	38.2%
2025-09-18	158,440	0	317,147	50.0%
2025-09-17	145,111	0	409,200	35.5%
2025-09-16	140,208	0	407,233	34.4%
2025-09-15	142,351	113	501,810	28.4%
2025-09-12	97,763	1,000	399,810	24.5%
2025-09-11	138,884	0	237,111	58.6%
2025-09-10	124,385	0	380,164	32.7%
2025-09-09	118,497	0	281,646	42.1%
2025-09-08	123,633	0	278,178	44.4%
2025-09-05	153,553	0	305,566	50.3%
2025-09-04	232,653	0	463,856	50.2%
2025-09-03	108,703	0	229,765	47.3%
2025-09-02	81,407	0	157,566	51.7%
2025-08-29	100,573	1,790	186,144	54.0%
2025-08-28	100,902	0	223,292	45.2%
2025-08-27	65,106	0	130,268	50.0%
2025-08-26	54,432	0	202,240	26.9%
2025-08-25	70,980	13	188,332	37.7%
2025-08-22	109,440	0	232,153	47.1%
2025-08-21	60,850	0	97,646	62.3%
2025-08-20	126,239	21	249,995	50.5%
2025-08-19	162,448	0	316,943	51.3%
2025-08-18	87,807	0	204,483	42.9%
2025-08-15	115,279	729	261,975	44.0%
2025-08-14	99,733	0	220,964	45.1%
2025-08-13	169,331	0	418,521	40.5%
2025-08-12	127,458	0	359,205	35.5%
2025-08-11	130,771	0	325,915	40.1%
2025-08-08	88,140	0	336,247	26.2%
2025-08-07	165,915	132	523,296	31.7%
2025-08-06	167,710	0	438,576	38.2%
2025-08-05	194,095	0	592,603	32.8%
2025-08-04	110,453	810	315,314	35.0%
2025-08-01	246,347	2,190	708,244	34.8%
2025-07-31	853,243	1,783	2,112,188	40.4%
2025-07-30	195,473	0	991,119	19.7%
2025-07-29	119,212	299	384,793	31.0%
2025-07-28	98,629	0	352,431	28.0%
2025-07-25	50,782	0	233,956	21.7%
2025-07-24	99,823	0	508,487	19.6%
2025-07-23	55,844	0	348,407	16.0%
2025-07-22	74,546	1,897	413,022	18.0%
2025-07-21	65,768	1,964	210,651	31.2%
2025-07-18	54,629	0	208,520	26.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam